Varespladib
| CAS No. | 172732-68-2 | Cat. No. | BCP01854 |
| Name | Varespladib | ||
| Synonyms | LY-315920;LY 315920;LY315920; A-002; A002; A 002;LY 333013;LY-333013;LY333013; | ||
| Formula | C21H20N2O5 | M. Wt | 380.4 |
| Description | LY315920 exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50 of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively. In BAL cells challenged with human sPLA2, LY315920 at doses ranging from 0.1 μM–3 μM reduces the formation of thromboxane mediated by human sPLA2 in a concentration-dependent manner with an IC50 of approximately 0.8 μM. In human conjunctival epithelial cell line (HCjE), LY315920 (10 μM) significantly inhibits all-trans-retinoic acid (RA) -induced membrane-associated mucin MUC16 expression by 100% at 24 hours and 99% at 48 hours. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Phospholipase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.